Updates in the Treatment of Secondary AML After the 2024 SOHO Annual Meeting - Episode 5
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss factors for picking intensive chemotherapy vs other regimens in acute myeloid leukemia.
Related Content: